Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol in Septic Shock due to VAP
NCT06592547Phase 2Completed
- Sponsor
- Alexandria University
- Start
- Apr 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of metoprolol in septic shock (2 arms), sponsored by Alexandria University. Primary endpoint: 28-day Mortality. Started Apr 2022; status: completed.
02
Drugs
metoprolol
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT06592547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06592547.